Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis.

Antoniades C, Demosthenous M, Tousoulis D, Antonopoulos AS, Vlachopoulos C, Toutouza M, Marinou K, Bakogiannis C, Mavragani K, Lazaros G, Koumallos N, Triantafyllou C, Lymperiadis D, Koutsilieris M, Stefanadis C.

Hypertension. 2011 Jul;58(1):93-8. doi: 10.1161/HYPERTENSIONAHA.110.168245. Epub 2011 Apr 25.

2.

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.

Lu TM, Lin SJ, Lin MW, Hsu CP, Chung MY.

Cardiovasc Diabetol. 2011 Feb 9;10:16. doi: 10.1186/1475-2840-10-16.

3.

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ.

J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32. doi: 10.1016/j.jacc.2010.05.034. Review.

4.

Oxidative stress as a mediator of cardiovascular disease.

Elahi MM, Kong YX, Matata BM.

Oxid Med Cell Longev. 2009 Nov-Dec;2(5):259-69. doi: 10.4161/oxim.2.5.9441. Review.

5.

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG.

PLoS Biol. 2010 Jun 29;8(6):e1000412. doi: 10.1371/journal.pbio.1000412. Review. No abstract available.

6.

Endothelial function as a functional expression of cardiovascular risk factors.

Reriani MK, Lerman LO, Lerman A.

Biomark Med. 2010 Jun;4(3):351-60. doi: 10.2217/bmm.10.61. Review.

7.

Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus.

Anderssohn M, Schwedhelm E, Lüneburg N, Vasan RS, Böger RH.

Diab Vasc Dis Res. 2010 Apr;7(2):105-18. doi: 10.1177/1479164110366053. Epub 2010 Mar 17. Review.

PMID:
20382774
8.

Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.

Nuno DW, Harrod JS, Lamping KG.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1469-77. doi: 10.1152/ajpheart.00407.2009. Epub 2009 Aug 7.

9.

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, Home PD.

Cardiovasc Diabetol. 2009 Jun 1;8:27. doi: 10.1186/1475-2840-8-27.

10.

Vascular endothelium in atherosclerosis.

Sima AV, Stancu CS, Simionescu M.

Cell Tissue Res. 2009 Jan;335(1):191-203. doi: 10.1007/s00441-008-0678-5. Epub 2008 Sep 17. Review.

PMID:
18797930
11.

Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice--possible dysfunction of receptor and/or receptor-G protein coupling.

Miike T, Kunishiro K, Kanda M, Azukizawa S, Kurahashi K, Shirahase H.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):401-10. doi: 10.1007/s00210-008-0261-3. Epub 2008 Jan 29.

PMID:
18228001
12.

The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perfused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase.

Guigas B, Naboulsi R, Villanueva GR, Taleux N, Lopez-Novoa JM, Leverve XM, El-Mir MY.

Cell Physiol Biochem. 2007;20(6):925-34. Erratum in: Cell Physiol Biochem. 2008;21(5-6):500.

13.

Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice.

Elmi S, Sallam NA, Rahman MM, Teng X, Hunter AL, Moien-Afshari F, Khazaei M, Granville DJ, Laher I.

Vascul Pharmacol. 2008 Jan;48(1):1-8. Epub 2007 Sep 15.

PMID:
17974492
14.

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.

Wilcken DE, Sim AS, Wang J, Wang XL.

Mol Genet Metab. 2007 Aug;91(4):309-17; discussion 308. Epub 2007 Jun 7. Review.

PMID:
17560156
15.

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss.

McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS.

J Clin Endocrinol Metab. 2006 May;91(5):1896-900. Epub 2006 Feb 28.

PMID:
16507636
16.

Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.

Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G.

Diabetologia. 2006 Feb;49(2):351-9. Epub 2005 Dec 21.

PMID:
16369774
18.

Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats.

Carello KA, Whitesall SE, Lloyd MC, Billecke SS, D'Alecy LG.

Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H209-16. Epub 2005 Aug 19.

19.

Protective effects of silybin on human umbilical vein endothelial cell injury induced by H2O2 in vitro.

Wang YK, Hong YJ, Huang ZQ.

Vascul Pharmacol. 2005 Oct;43(4):198-206. Epub 2005 Aug 18.

PMID:
16111923
20.

The human liver clears both asymmetric and symmetric dimethylarginine.

Siroen MP, van der Sijp JR, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA.

Hepatology. 2005 Mar;41(3):559-65.

PMID:
15726655

Supplemental Content

Support Center